| Met-21 | Use of bevacizumab |
|---|---|
| In patients with metastatic breast cancer receiving paclitaxel or capecitabine as first-line cytostatic therapy, bevacizumab can be administered additionally to improve the therapeutic outcome. | |
| GCP | (NBOCC2010; Robert NJ et al. 2011) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.